The Use Of Intravenous Immunoglobulin For The Treatment Of Severe Covid-19: Case Presentation For Three Patients

Although the treatment of the hyperinflammatory response due to COVID-19 has not yet been found, high-dose corticosteroids, interleukin receptor blockers and intravenous immunoglobulin (IVIG) are used to improve the hyperinflammatory response. In this article, we aimed to share our experiences with 3 patients who received IVIG therapy in ICU. (English) [ABSTRACT FROM AUTHOR] COVID-19’a bagli gelisen hiperinflamatuvar yanitin kesin bir tedavisinin henuz bulunamamis olmasina ragmen, yuksek doz kortikosteroid, interlokin reseptor blokerleri ve intravenoz immunoglobulin (IVIG) tedavisi bugunlerde kullanilmaktadir. Biz bu makalemizde, yogun bakimimizda IVIG tedavisi uyguladigimiz 3 Covid-19 hastasindaki tecrubelerimizi paylasmayi amacladik. (Turkish) [ABSTRACT FROM AUTHOR] Copyright of Anestezi Dergisi (JARSS) is the property of Logos Medical Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)